13D/13G Filings - TANG CAPITAL MANAGEMENT, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-06-12
4:27 pm
Unchanged
2025-06-11 13D iTeos Therapeutics, Inc.
ITOS
TANG CAPITAL MANAGEMENT, LLC 3,826,692
9.990%
0
(Unchanged)
Filing
History
2025-05-23
4:15 pm
Sale
2025-05-21 13D Acelyrin, Inc.
SLRN
TANG CAPITAL MANAGEMENT, LLC 0
0.000%
-8,824,693decrease
(Position Closed)
Filing
History
2025-05-19
4:15 pm
Sale
2025-05-15 13D Allakos Inc.
ALLK
TANG CAPITAL MANAGEMENT, LLC 10,000
100.000%
-8,683,687decrease
(-99.88%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G ALX Oncology Holdings Inc.
ALXO
TANG CAPITAL MANAGEMENT, LLC 3,158,265
5.900%
3,158,265increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Bolt Biotherapeutics, Inc.
BOLT
TANG CAPITAL MANAGEMENT, LLC 3,812,773
9.900%
3,812,773increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Compass Therapeutics, Inc.
CMPX
TANG CAPITAL MANAGEMENT, LLC 11,052,632
8.000%
3,652,632increase
(+49.36%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Cybin Inc.
CYBN
TANG CAPITAL MANAGEMENT, LLC 1,830,097
9.100%
500,000increase
(+37.59%)
Filing
History
2025-05-15
4:15 pm
Sale
2025-03-31 13G CytomX Therapeutics, Inc.
CTMX
TANG CAPITAL MANAGEMENT, LLC 6,717,825
8.400%
-1,093,935decrease
(-14.00%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Evolus, Inc.
EOLS
TANG CAPITAL MANAGEMENT, LLC 4,997,399
7.900%
150,000increase
(+3.09%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Journey Medical Corporation
DERM
TANG CAPITAL MANAGEMENT, LLC 1,854,596
8.000%
330,658increase
(+21.70%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G KalVista Pharmaceuticals, Inc.
KALV
TANG CAPITAL MANAGEMENT, LLC 4,941,798
9.900%
620,251increase
(+14.35%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Outlook Therapeutics, Inc.
OTLK
TANG CAPITAL MANAGEMENT, LLC 1,900,000
5.600%
1,900,000increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Reviva Pharmaceuticals Holdings, Inc.
RVPH
TANG CAPITAL MANAGEMENT, LLC 3,910,304
7.800%
3,910,304increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Adicet Bio, Inc.
ACET
TANG CAPITAL MANAGEMENT, LLC 8,223,612
9.900%
6,652increase
(+0.08%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Elevation Oncology, Inc.
ELEV
TANG CAPITAL MANAGEMENT, LLC 6,043,921
9.990%
6,043,921increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-05-13 13G iTeos Therapeutics, Inc.
ITOS
TANG CAPITAL MANAGEMENT, LLC 3,826,692
9.990%
3,604,976increase
(+1625.94%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Precision BioSciences, Inc.
DTIL
TANG CAPITAL MANAGEMENT, LLC 673,332
6.400%
50,000increase
(+8.02%)
Filing
History
2025-05-15
4:15 pm
Purchase
2025-03-31 13G Tarsus Pharmaceuticals, Inc.
TARS
TANG CAPITAL MANAGEMENT, LLC 2,454,797
5.900%
2,454,797increase
(New Position)
Filing
History
2025-05-02
4:15 pm
Purchase
2025-05-02 13D HilleVax, Inc.
HLVX
TANG CAPITAL MANAGEMENT, LLC 4,920,000
9.800%
4,920,000increase
(New Position)
Filing
History
2025-05-01
4:15 pm
Purchase
2025-04-24 13G Spyre Therapeutics, Inc.
SYRE
TANG CAPITAL MANAGEMENT, LLC 3,200,000
5.300%
3,200,000increase
(New Position)
Filing
History
Goto 0, 1, 2, Next